Publications
- Targeted treatment with osimertinib in the adjuvant treatment of a patient with non‐small cell lung cancer – case report2023 | Third Faculty of Medicine
- Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Real-life Effectiveness of Afatinib Versus Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Real-life effectiveness of first-line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry2020 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Effect of clinical parameters on second- and third-line erlotinib treatment of EGFR wild type patients with advanced NSCLC2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Second Faculty of Medicine
- Treatment of malignant pleural mesothelioma in the Czech Republic2019 | Faculty of Medicine in Pilsen, Central Library of Charles University
- EGFR mutations in non-small cell lung cancer - treatment options2019 | Third Faculty of Medicine
- Small cell lung cancer treatment - immunotherapy2019 | Third Faculty of Medicine
- Erlotinib in the first line treatment of the metastatic non-small cell lung cancer2018 | Third Faculty of Medicine
Loading network view...